AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimibrit M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Elbrit Life Sciences

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimibrit M 0.5 Tablet PR

DiaBeb M 0.5mg tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. These tablets help regulate blood glucose levels. DiaBeb M 0.5mg should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical guidance can lead to elevated glucose levels, increasing the risk of complications including nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (blood counts and liver function) are recommended.

Primary Ingredients of Glimibrit M 0.5 Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glimibrit M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimibrit M 0.5 Tablet PR:

Follow your doctor's instructions or the product label for proper administration. Consume Glimibrit M 0.5 Tablet PR with a meal.

Common Side effects of Glimibrit M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimibrit M 0.5 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Glimibrit M 0.5 Tablet PR with a meal.

How Glimibrit M 0.5 Tablet PR works:

Glimibrit M 0.5 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimibrit M 0.5 Tablet PR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimibrit M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimibrit M 0.5 Tablet PR are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimibrit M 0.5 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimibrit M 0.5 Tablet PR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimibrit M 0.5 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in cases of severe liver disease.

What if you forget to take Glimibrit M 0.5 Tablet PR :

Should you forget a Glimibrit M 0.5 Tablet PR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimibrit M 0.5 Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimibrit M 0.5 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimibrit M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimibrit M 0.5 Tablet PR and seek immediate medical attention.
Glimibrit M 0.5 Tablet PR combines glimepiride and metformin to treat type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimibrit M 0.5 Tablet PR may cause common side effects such as hypoglycemia (low blood sugar), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimibrit M 0.5 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimibrit M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimibrit M 0.5 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimibrit M 0.5 Tablet PR
80
MRP 97
17% off